Drug
VX 814
VX 814: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-814 NCT04167345 | Phase 2 | Alpha 1-Antitrypsin Deficiency |
Latest
No recent events.
Follow VX 814 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.